These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 24831828

  • 1. The association of red cell distribution width with in-stent restenosis in patients with stable coronary artery disease.
    Kurtul A, Murat SN, Yarlioglues M, Duran M, Karadeniz M, Ergun G, Akyel A, Mendi MA, Oksuz F.
    Platelets; 2015; 26(1):48-52. PubMed ID: 24831828
    [Abstract] [Full Text] [Related]

  • 2. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
    Zhao K, Li YJ, Gao S.
    Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
    [Abstract] [Full Text] [Related]

  • 3. Preprocedural red blood cell distribution width predicts bare metal stent restenosis.
    Yildiz A, Tekiner F, Karakurt A, Sirin G, Duman D.
    Coron Artery Dis; 2014 Sep; 25(6):469-73. PubMed ID: 24614629
    [Abstract] [Full Text] [Related]

  • 4. Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
    Tanındı A, Ekici B, Töre HF.
    Turk Kardiyol Dern Ars; 2015 Jul; 43(5):457-64. PubMed ID: 26148078
    [Abstract] [Full Text] [Related]

  • 5. The Relationship Between Lymphocyte-to-Monocyte Ratio and Bare-Metal Stent In-Stent Restenosis in Patients With Stable Coronary Artery Disease.
    Murat SN, Yarlioglues M, Celik IE, Kurtul A, Duran M, Kilic A, Oksuz F.
    Clin Appl Thromb Hemost; 2017 Apr; 23(3):235-240. PubMed ID: 26759373
    [Abstract] [Full Text] [Related]

  • 6. Red cell distribution width in coronary heart disease: prediction of restenosis and its relationship with inflammatory markers and lipids.
    Qian H, Luo Z, Xiao C, Chen J, Li D, Xu H, He P, Zhou X, Zhang T, Min X.
    Postgrad Med J; 2018 Sep; 94(1115):489-494. PubMed ID: 30301834
    [Abstract] [Full Text] [Related]

  • 7. Association between plasma BMP-2 and in-stent restenosis in patients with coronary artery disease.
    Zheng WP, Yang M, Su LX, Ning Y, Wen WW, Xin MK, Zhao X, Zhang M.
    Clin Chim Acta; 2017 Aug; 471():150-153. PubMed ID: 28558956
    [Abstract] [Full Text] [Related]

  • 8. The relationship between fibrinogen-to-albumin ratio and in-stent restenosis in patients with coronary artery disease undergoing drug-eluting stenting.
    Chen T, Sun JL, Zhang J.
    Coron Artery Dis; 2020 Nov; 31(7):586-589. PubMed ID: 32271235
    [Abstract] [Full Text] [Related]

  • 9. High red blood cell distribution width is closely associated with in-stent restenosis in patients with unstable angina pectoris.
    Geng N, Su G, Wang S, Zou D, Pang W, Sun Y.
    BMC Cardiovasc Disord; 2019 Jul 24; 19(1):175. PubMed ID: 31340761
    [Abstract] [Full Text] [Related]

  • 10. Relationship of interleukin-6-572C/G promoter polymorphism and serum levels to post-percutaneous coronary intervention restenosis.
    Gao J, Liu Y, Cui RZ, Mao YM, Zhou J, Chen Q, Zhao FM, Yang GM.
    Chin Med J (Engl); 2013 Mar 24; 126(6):1019-25. PubMed ID: 23506572
    [Abstract] [Full Text] [Related]

  • 11. Preprocedural Albumin Levels and Risk of In-Stent Restenosis After Coronary Stenting With Bare-Metal Stent.
    Celik IE, Yarlioglues M, Kurtul A, Duran M, Koseoglu C, Oksuz F, Aksoy O, Murat SN.
    Angiology; 2016 May 24; 67(5):478-83. PubMed ID: 26243483
    [Abstract] [Full Text] [Related]

  • 12. Usefulness of preprocedural serum uric acid level to predict restenosis of bare metal stents.
    Turak O, Canpolat U, Özcan F, Mendi MA, Oksüz F, Işleyen A, Gürel OM, Çay S, Aras D, Aydoğdu S.
    Am J Cardiol; 2014 Jan 15; 113(2):197-202. PubMed ID: 24157191
    [Abstract] [Full Text] [Related]

  • 13. A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio.
    Ucar FM.
    BMC Cardiovasc Disord; 2016 Oct 03; 16(1):186. PubMed ID: 27716070
    [Abstract] [Full Text] [Related]

  • 14. Clinical presentation and outcomes of coronary in-stent restenosis across 3-stent generations.
    Magalhaes MA, Minha S, Chen F, Torguson R, Omar AF, Loh JP, Escarcega RO, Lipinski MJ, Baker NC, Kitabata H, Ota H, Suddath WO, Satler LF, Pichard AD, Waksman R.
    Circ Cardiovasc Interv; 2014 Dec 03; 7(6):768-76. PubMed ID: 25466551
    [Abstract] [Full Text] [Related]

  • 15. Remnant Lipoprotein Cholesterol Independently Associates With In-Stent Restenosis After Drug-Eluting Stenting for Coronary Artery Disease.
    Xu X, Pandit RU, Han L, Li Y, Guo X.
    Angiology; 2019 Oct 03; 70(9):853-859. PubMed ID: 31167539
    [Abstract] [Full Text] [Related]

  • 16. The value of serum visfatin in predicting in-stent restenosis of drug-eluting stents.
    Wu XA, Xie G, Li XQ, Wu HT, Wang X.
    Clin Chim Acta; 2018 Apr 03; 479():20-24. PubMed ID: 29305846
    [Abstract] [Full Text] [Related]

  • 17. The relationship between the high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P) and coronary in-stent restenosis.
    Jing XD, Wei XM, Deng SB, Du JL, Liu YJ, She Q.
    Clin Chim Acta; 2015 Jun 15; 446():248-52. PubMed ID: 25958848
    [Abstract] [Full Text] [Related]

  • 18. Association of the Endothelial Nitric Oxide Synthase Gene T786C Polymorphism with In-Stent Restenosis in Chinese Han Patients with Coronary Artery Disease Treated with Drug-Eluting Stent.
    Zeng WP, Zhang R, Li R, Luo JF, Hu XF.
    PLoS One; 2017 Jun 15; 12(1):e0170964. PubMed ID: 28129392
    [Abstract] [Full Text] [Related]

  • 19. Serum concentration of insulin-like growth factor-I, but not tumor necrosis factor-alpha, measured twelve months after stenting of the infarct-related artery, is associated with in-stent restenosis.
    Szkodzinski J, Hudzik B, Romanowski W, Wilczek K, Danikiewicz A, Gasior M, Polonski L, Zubelewicz-Szkodzinska B.
    J Biol Regul Homeost Agents; 2010 Jun 15; 24(2):149-56. PubMed ID: 20487628
    [Abstract] [Full Text] [Related]

  • 20. Relationship between preheparin lipoprotein lipase mass concentration in serum and bare metal stent restenosis.
    Hitsumoto T, Takahashi M, Iizuka T, Shirai K.
    J Cardiol; 2006 Aug 15; 48(2):65-73. PubMed ID: 16948449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.